Viewing Study NCT00081068


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2026-03-04 @ 8:32 AM
Study NCT ID: NCT00081068
Status: WITHDRAWN
Last Update Posted: 2013-01-08
First Post: 2004-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module